Literature DB >> 21467817

Podoplanin expression in odontomas: clinicopathological study and immunohistochemical analysis of 86 cases.

Patricia González-Alva1, Harumi Inoue, Yuji Miyazaki, Hozumi Tsuchiya, Yoshihiro Noguchi, Kentaro Kikuchi, Fumio Ide, Sachiyo Ishihara, Tadashi Katayama, Hideaki Sakashita, Kaoru Kusama.   

Abstract

Podoplanin, a sialomucin-like transmembrane glycoprotein, is currently used as a specific marker for lymphatic vessels. However, podoplanin expression has also been linked to tooth development. To investigate the expression of podoplanin in odontomas, 86 tissue samples were classified and then analyzed using immunohistochemical methods. Formalin-fixed, paraffin-embedded specimens were collected and classified, followed by immunohistochemical examination. The majority of the odontomas (66.3%) were the compound type, and the remainder (33.7%) were the complex type. The patients ranged in age from 2 to 89 years (mean, 23.9 years), and 45 (52.3%) of them were male and 41 (47.7%) were female. The most common location for complex odontomas was the molar region of the mandibular bone, and that for compound odontomas was the maxillary incisor region. Immunohistochemistry revealed that developing and mature odontoblasts, Tomes' fibers, and pulp cells near podoplanin-positive odontoblasts were positive for podoplanin. In addition, podoplanin positivity was evident in secretory ameloblasts, but not in mature ameloblasts. The pattern of podoplanin expression in odontomas corresponds to development of the tooth germ, and appears to be influenced by the stage of differentiation of the lesion, suggesting that the protein may participate in the process of differentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21467817     DOI: 10.2334/josnusd.53.67

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  9 in total

1.  Immunohistochemical evaluation of podoplanin in odontogenic tumours & cysts using anti-human podoplanin antibody.

Authors:  Namrata Singhal; Nitin Khanduri; Deepak Kurup; Brijesh Gupta; Pranjan Mitra; Roshani Chawla
Journal:  J Oral Biol Craniofac Res       Date:  2017-05-17

Review 2.  The diagnostic usefulness of immunohistochemistry for odontogenic lesions.

Authors:  Keith D Hunter; Paul M Speight
Journal:  Head Neck Pathol       Date:  2014-11-20

3.  Compound Odontoma in Anterior Mandible-A Case Report.

Authors:  Eswara Uma
Journal:  Malays J Med Sci       Date:  2017-06-30

4.  Expression of Podoplanin in Laryngeal Squamous Cell Carcinoma and Dysplasia.

Authors:  Badawia Bayoumy Ibrahim; Mostafa Mohamed Salem; Rasha Ahmed Khairy; Reema Abdul Rahman Al Gunaid
Journal:  J Clin Diagn Res       Date:  2017-05-01

5.  Role of podoplanin expression in deciding the invasive potential of ameloblastoma - A retrospective IHC study.

Authors:  Sindhu M Ganvir; Pratima G Khobragade; Swati A Bamane; Ramnivas Kumavat; Amit Dalmia
Journal:  J Oral Biol Craniofac Res       Date:  2016-07-14

6.  Are podoplanin and ezrin involved in the invasion process of the ameloblastomas?

Authors:  Y F Costa; K C Tjioe; S Nonogaki; F A Soares; J R Pereira Lauris; D Tostes Oliveira
Journal:  Eur J Histochem       Date:  2015-02-24       Impact factor: 3.188

7.  Anxiolysis in the Surgical Management of a Compound Odontoma in a Pediatric Patient.

Authors:  Pier Paolo Poli; Luca Creminelli; Emma Grecchi; Silvia Pieriboni; Gregorio Menozzi; Carlo Maiorana
Journal:  Case Rep Dent       Date:  2019-04-02

8.  Analysis of Protein Immunoexpression and Its Interrelationship in the Pathogenesis of Odontomas and Ameloblastic Fibro-Odontomas: A Systematic Review.

Authors:  Glória Maria de França; Juliana Campos Pinheiro; Dennys Ramon de Melo Fernandes Almeida; Gabriel Gomes da Silva; Kênio Costa de Lima; Pedro Paulo de Andrade Santos; Hébel Cavalcanti Galvão
Journal:  Head Neck Pathol       Date:  2021-01-04

9.  The relationship between ezrin and podoplanin expressions in keratocystic odontogenic tumors.

Authors:  Denise Tostes Oliveira; Laís Priscila de Santis; Agnes Assao; Kellen Cristine Tjioe; Suely Nonogaki; José Roberto Pereira Lauris; Fernando Augusto Soares
Journal:  BMC Oral Health       Date:  2014-12-05       Impact factor: 2.757

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.